Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
1.110
-0.030 (-2.64%)
Nov 4, 2024, 4:00 PM EST - Market closed

Processa Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2015
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2015
Market Capitalization
4818777099
Upgrade
Market Cap Growth
-27.52%-53.15%-77.16%10.52%-29.44%-29.07%
Upgrade
Enterprise Value
129587198
Upgrade
Last Close Price
1.156.6922.0098.00131.90360.00
Upgrade
PE Ratio
--0.79-0.65-6.57-2.60-25.74
Upgrade
PB Ratio
1.011.652.353.023.0412.32
Upgrade
P/FCF Ratio
-0.40-1.02-1.83-8.83-22.17-35.91
Upgrade
P/OCF Ratio
-0.40-1.02-1.83-8.83-22.17-35.91
Upgrade
EV/EBITDA Ratio
0.08-0.14-0.45-5.38-12.63-31.45
Upgrade
EV/EBIT Ratio
0.08-0.14-0.43-5.02-11.05-25.03
Upgrade
EV/FCF Ratio
0.09-0.19-0.91-6.66-22.63-35.81
Upgrade
Debt / Equity Ratio
0.030.030.030.000.010.13
Upgrade
Debt / FCF Ratio
-0.01-0.02-0.02-0.01-0.10-0.37
Upgrade
Quick Ratio
2.376.446.5117.0612.820.58
Upgrade
Current Ratio
3.977.718.4018.8713.270.85
Upgrade
Return on Equity (ROE)
-211.71%-178.52%-166.43%-47.20%-93.14%-37.91%
Upgrade
Return on Assets (ROA)
-113.11%-99.41%-72.18%-27.98%-22.29%-21.05%
Upgrade
Return on Capital (ROIC)
-132.05%-111.54%-76.12%-29.61%-24.90%-25.93%
Upgrade
Earnings Yield
-307.74%-134.94%-155.91%-14.84%-20.69%-3.40%
Upgrade
FCF Yield
-297.01%-97.87%-54.61%-11.32%-4.51%-2.78%
Upgrade
Buyback Yield / Dilution
-117.51%-62.83%-5.16%-104.27%-35.72%-3.63%
Upgrade
Total Shareholder Return
-117.51%-62.83%-5.16%-104.27%-35.72%-3.63%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.